Oncotype DX vs Tempus

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Oncotype DX

Guideline recommended
Variable

Breast recurrence risk

Tempus

CLIA certified
Variable

648 genes

Test Performance

FeatureOncotype DXTempus
PriceVariableVariable
Cancers DetectedBreast recurrence risk648 genes
SensitivityN/AN/A
SpecificityN/AN/A
Sample TypeTumor tissueTumor tissue + blood
FDA StatusGuideline recommendedCLIA certified